Dr. Yang Shu is a productive biomedical researcher specializing in molecular mechanisms underlying inflammatory disorders, renal injury, fibrosis, ferroptosis regulation, metabolic signaling pathways, and therapeutic bioactive compounds. With 56 publications, 1,149 citations, and an h-index of 21, the researcher demonstrates strong scholarly influence and sustained research visibility in translational disease biology. Collaborative engagement with a broad international co-author network (over 190 collaborators) reflects interdisciplinary integration across cell signaling, immunometabolism, and pharmacological intervention studies. Contributions advance mechanistic understanding of chronic disease progression and support development of targeted therapeutic strategies with potential clinical and public-health relevance, strengthening global biomedical innovation and evidence-based treatment perspectives .